Literature DB >> 1819733

Platelet-activating factor may mediate dexamethasone-induced gastric damage in the rat.

J Filep1, F Hermán, P Braquet.   

Abstract

The possible role of platelet-activating factor (PAF) in dexamethasone-induced gastric mucosal damage was studied in rats. PAF was measured by a platelet aggregation assay. The identity of the PAF-like product recovered from gastric tissues was ascertained by thin-layer chromatography and high-pressure liquid chromatography. Low levels of PAF were detected in the normal rat stomach, while in dexamethasone-treated animals PAF levels were significantly higher. Pretreatment of the animals with BN 52021, a specific PAF receptor antagonist, significantly attenuated dexamethasone-induced mucosal injury. These findings suggest that PAF may be a mediator of mucosal damage induced by glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1819733     DOI: 10.1007/BF02536566

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  21 in total

1.  Potential endogenous inhibitor of prostaglandin synthetase in plasma: failure to inhibit cyclo-oxygenase in platelets and the gastric mucosa.

Authors:  B J Whittle
Journal:  J Pharm Pharmacol       Date:  1978-07       Impact factor: 3.765

2.  Mechanisms contributing to gastric motility changes induced by PAF-acether and endotoxin in rats.

Authors:  J V Esplugues; B J Whittle
Journal:  Am J Physiol       Date:  1989-02

3.  Antihypertensive activity of an alkyl ether analog of phosphatidylcholine.

Authors:  M L Blank; F Snyder; L W Byers; B Brooks; E E Muirhead
Journal:  Biochem Biophys Res Commun       Date:  1979-10-29       Impact factor: 3.575

Review 4.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

5.  Gastric mucosal damage induced by local intra-arterial administration of Paf in the rat.

Authors:  J V Esplugues; B J Whittle
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

6.  Glomeruli from ischemic rat kidneys produce increased amounts of platelet activating factor.

Authors:  A López-Farré; M Torralbo; J M López-Novoa
Journal:  Biochem Biophys Res Commun       Date:  1988-04-15       Impact factor: 3.575

7.  Effects of the specific platelet-activating factor antagonists, BN 52021 and BN 52063, on various experimental gastrointestinal ulcerations.

Authors:  P Braquet; A Etienne; J M Mencia-Huerta; F Clostre
Journal:  Eur J Pharmacol       Date:  1988-06-10       Impact factor: 4.432

8.  Gastrointestinal plasma leakage in endotoxic shock. Inhibition by prostaglandin E2 and by a platelet-activating factor antagonist.

Authors:  J L Wallace; G Steel; B J Whittle
Journal:  Can J Physiol Pharmacol       Date:  1987-07       Impact factor: 2.273

9.  Potent ulcerogenic actions of platelet-activating factor on the stomach.

Authors:  A C Rosam; J L Wallace; B J Whittle
Journal:  Nature       Date:  1986 Jan 2-8       Impact factor: 49.962

10.  Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants.

Authors:  J L Wallace; B J Whittle
Journal:  Prostaglandins       Date:  1986-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.